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Abstract
Ear, Nose & Throat (ENT) and acute respiratory tract (ART) infections 
are the main causes of inappropriate antibiotic prescribing. To evaluate 
the antibiotics prescribing practices for these infections, we conduct 
an observational study with 23 general practionners (GPs) working in 
private offices of the East Central Region of Tunisia. 
Among the 374 patients presenting ENT or ART infections, 193 
were men (51.6%). The mean age was 45.6 ± 16.7 years. Comorbidi-
ties were present in 174 patients (51.9%). The first visit was made 3.7 
± 6 days after the beginning of the symptoms. The main diagnoses 
are acute bronchitis (37.4%), tonsillitis (33.4%) and acute maxillary 
sinusitis (20.9%). Additional tests (chest-X-ray and Lab-test) were 
prescribed for only 75 patients (20%). An antibiotic was prescribed 
for 360 patients (96.2%), for an average of 9.1 ± 2.3 days. The 
main prescribed antibiotics are β-lactams (58.3%), fluoroquinolones 
(23.5%) and macrolides (15.6%). Overall, the rate of inappropriate 
antibiotic prescription was 34.1%, the highest rates was noted in 
Exacerbation of the COPD (73.2%) and pneumonia (42.1%). Anti-
pyretics and corticosteroids were prescribed in 71.4% and 44.7% 
respectively. The clinical success rate was noted in 375 cases (89%). 
The average cost of an infectious episode amounts to about $ 45 
± 20. 
This study underlines over-prescribing of antibiotics with unne-
cessary additional costs which may be related to the non-use of 
diagnostic tools. National guidelines should be developed in order to 
reduce unnecessary antibiotic prescription and emerging of bacterial 
resistance. 
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Introduction
Acute respiratory tract infections are the commonest 
acute conditions managed in general practice. They 
are also the main causes of antibiotic prescribing. 
These antibiotic prescriptions are often inappropria-
te or unnecessary and may contribute to the deve-
lopment of resistance among the causative bacterial 
agents of community infection [1-4]. In Tunisia, the 
rates of antibiotic prescriptions remain high in ge-
neral practice [5, 6]. 
The high rate of antibiotic prescription may be 
explained by the absence of national recommen-
dations, the lack of diagnostic tools that can help 
to guide the prescription, probably pressure from 
patients and the absence of education actions to 
promote the appropriate use of antibiotics.
The antibiotic prescribing practices of general 
practitioners (GPs) has been rarely studied in Tunisia. 
Knowing the attitude of peers, when facing an Ear-
Nose-Throat (ENT) and respiratory tract infection, 
can encourage them to change their habits.
The AMIRAT (Antibiotherapy Management In 
Respiratory Infections in Ambulatory in Tunisia) 
study aims to evaluate the prescribing practices of 
general practitioners when facing an ENT or a res-
piratory infection in Tunisia and their direct cost. 
Patients & Methods 
This observational study on the use of antibiotics in 
ENT and respiratory infections, was conducted from 
February 1st, 2014 (date of the first inclusion) to 
November 25th, 2014 with 23 GPs (General practi-
tioners) working in private offices of the East Central 
Region of Tunisia (Governorates of Sousse, Monastir 
and Kairouan) and who have agreed to conduct 
the study. 
The study was approved by ethic committee of 
the Teaching Hospital of Monastir and conducted 
in accordance with Good Clinical Practice [7] and 
the Declaration of Helsinki [8]. Written informed 
consent was obtained from all participants prior to 
study commencement.
The inclusion criteria was men or women aged 18 
years or more with a clinical symptoms of an upper 
or lower respiratory tract infection and possibility of 
a clinical monitoring.
Patients who do not meet the inclusion criteria, 
pregnant women and patients who require hospi-
talization were excluded.
The clinical monitoring includes two visits, the in-
clusion visit (V1) and the visit after 8 ± 3 days (V2).
The GPs were free to decide which laboratory 
or radiological tests may be performed and which 
antibiotics, monotherapy or combination, should be 
prescribed. The diagnosis was based on definitions 
of ENT and respiratory tract infections (pharyngitis, 
acute otitis media, acute maxillary sinusitis, acute 
bronchitis, pneumonia, acute exacerbation of chro-
nic obstructive pulmonary disease-COPD) [9] and 
provided to prescribers with the case report form 
(CRF).
The primary objective was to evaluate antibiotic 
prescription (drug, dosage regimen and duration) 
related to the clinical diagnosis.
The secondary objective was to estimate the glo-
bal cost of clinical entity. 
The diagnosis were analysed by age. In the eva-
luation of prescription, the antibiotic prescription 
was considered as inappropriate when the antibiotic 
spectrum of activity does not include the bacteria 
usually responsible for the infection or the antibio-
tic is unnecessary for the responsible bacteria or 
when the dose and duration of the antibiotic are 
insufficient. The clinical success of treatment was 
evaluated by the treating physician.
The calculation of costs was based on the public 
prices of drugs, according to the nomenclature 
of the National Health Insurance Fund (NHIF) for 
the year of the study and according to the amou-
nt spent for additional tests. The NHIF estimates 
the cost of a consultation was 18 Tunisian dinars 
(TND).
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Data were entered on the Epi Data, and analysed 
using the STATA© software. 
A statistical analysis was carried out, p-value less 
than 5% was considered as statistically significant.
Results
The study involved 374 patients, among them 193 
men (51.6%) and 181 women (48.4%). The mean 
age was 45.6 ± 16.7 years. More than three quarters 
of the patients (77.5%) live in urban areas, 86.4% 
were schooled, 91.7% had a satisfactory socioeco-
nomic level and 72% were affiliated with the NHIF.
Comorbidities were noted in 174 patients (51.9%). 
The commonest comorbidities were hypertension 
(15.2%), chronic respiratory disease (13.4%) and 
diabetes (9.9%). Seven patients (1.9%) had a beta-
lactam’s hypersensitivity. Body mass index (BMI) 
showed overweight (BMI: 25 to 29.9 kg/m2) in 142 
patients (38%) and obesity (BMI ≥ 30 kg/m2) in 69 
patients (20%).
The first visit was made after 3.7 ± 6 days (me-
dian: 2 days) after the beginning of the symptoms.
The main clinical diagnoses are shown in Table 
1. Only one diagnosis was retained in 330 patients 
(88.2%) and two or more diagnoses in 44 cases 
(11.8%). The most frequent diagnostic combinations 
were tonsillitis with acute bronchitis (10 cases) and 
acute otitis media with acute bronchitis (10 cases).
The analysis of investigated patients according 
to age shows that tonsillitis was significantly more 
prevalent among young patients, and the frequen-
cy decrease significantly with age, from 48.3% in 
patients between 18 to 29 years to 12% in patients 
aged 60 years and older (p< 0.001). It was the same 
for acute maxillary sinusitis with 28.8% to 13.3%, 
respectively (p=0.002). 
In contrast, the frequency of acute bronchitis, 
pneumonia and chronic obstructive pulmonary di-
sease (COPD) exacerbations increased significantly 
with age, from patients aged 18-29 years to patients 
older than 60 years, 1.1% to 8% (p=0.009), 22.5% 
to 46,7% (p=0.04) and 0% to 28% (p<0.001) res-
pectively. 
Additional tests were prescribed for 75 patients 
(20%). The main additional requested tests were 
chest X-ray (n=54, 14.4%), C-reactive protein (n=24, 
6.4%), fasting plasma glucose (n=22, 5.9%) and 
complete blood count (n=22, 5.9%). 
An antibiotic was prescribed for 360 patients 
(96.2%), 347 patients received only one antibiotic 
and 13 (3.5%) received two or more. The main pres-
cribed antibiotics are shown in Table 2. 
Table 1. The main clinical diagnosis of patients.
Domains/Facets Number %
One main disease 330 88.2
Acute bronchitis 116 31.0
Tonsillitis 99 26.5
Acute maxillary sinusitis 57 15.2
Exacerbations of COPDs 28 7.5
Pneumonia 16 4.3
Acute otitis media 12 3.2
Others 2 0.5
More than one disease 44 11.8
Total 374 100.0
Table 2.  The main prescribed antibiotics.
Antibiotics
Frequencies
%
β-lactams
Penicillins
Amoxicillin-clavulanic acid 
41.8
71.5
Amoxicillin 26.5
Penicillin V 2.0
Cephalosporins
Cefuroxime (2nd GC)
16.5
65.6
Cefpodoxime (3th GC) 31.1
Cefixime (3th GC) 3.3
Quinolones
Fluoroquinolones
Levofloxacin 
23.5
79.5
Gemifloxacin 11.3
Ciprofloxacin/ofloxacin 9.2
Macrolides 15.6
Tetracyclines 0.5
Others 1.5
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Table 4.  Antibiotic prescription practices during respiratory infections.
Penicillins C2G C3G Tetracyclines Macrolides Fluoro-quinolones
Two antibiotics 
or more
% % % % % % %
Diagnostic items
One clinical feature 42.5 11 6 0.6 15.1 22.3 2.4
Acute bronchitis 38.9 5.3 2.7 1.8 17.7 31.9 1.8
Tonsillitis 45.7 18.5 16.3 0 17.4 1.1 1.1
Acute maxillary sinusitis 42.9 21.4 1.8 0 10.7 21.4 1.8
Exacerbations of COPDs 35.7 0 0 0 0 60.7 3.6
Pneumonia 43.8 0 0 0 18.8 25 12.4
Acute otitis media 72.7 0 0 0 18.2 9.1 0
Others 0 0 0 0 50 0 50
More than one diagnosis 29.3 7.3 2.4 0 22 31.7 6.8
Total 40.9 10.6 5.6 0.6 15.9 23.4 3.1
C2G: Second generation cephalosporin, C3G: third generation cephalosporin.
Table 3.  Frequency of the prescribed antibiotics ac-
cording to clinical diagnosis of patients.
Number of 
patients
Prescribed antibiotics
Number %
One clinical feature 330 319 96.6
Acute bronchitis 116 113 97.4
Tonsillitis 99 92 92.9
Acute maxillary sinusitis 57 56 98.2
Exacerbations of COPDs 28 28 100
Pneumonia 16 16 100
Acute otitis media 12 12 100
Others 2 2 100
More than one 
diagnosis
44 41 93.2
The frequency and the classes of prescribed anti-
biotics as well as duration according to the clinical 
diagnosis of patients are shown in Tables 3, 4 and 5.
It should be noted that the amoxicillin-clavula-
nic acid is frequently prescribed during tonsillitis 
(15.6%), viral or streptococcal infections, and acu-
te bronchitis (33.8%), usually viral infections. The 
fluoroquinolones are more frequently prescribed for 
exacerbation of COPD.
Except for acute bronchitis, antibiotic prescription 
was evaluated during the other infections to check 
if it was appropriate or not to the bacteria thought 
to be responsible, to the mechanisms of resistance 
and known resistance of bacteria based on local 
epidemiological data. In most cases, the combina-
tion was considered as not justified. Thus, the an-
tibiotic treatment was considered as inappropriate 
in 88/207 (42.5%) prescriptions (Table 6). The two 
main causes were the prescription of amoxicillin-cla-
vulanic acid during tonsillitis, non-antipneumococcal 
fluoroquinolones, when streptococci or streptococ-
cus pneumoniae are presumed to be responsible 
for infection (between tonsilitis and acute maxillary 
sinusitis, pneumonia), and unnecessary combination 
of antibiotics. (Table 7)
A group of at-risk patients including 79 people 
(21.9%) aged 65 and more and/or with diabetes 
and/or heart failure and/or immune suppression was 
identified. Among these patients, 50.6% had acu-
te bronchitis, 25.3% exacerbation of COPD, 20.3% 
tonsillitis, 7.6% pneumonia, 2.5% otitis and 1.3% 
other infections.
Three hundred and sixty-five patients (365, 97.6%) 
received a concomitant treatment. The prescribed 
drugs were antipyretics (71.4%), corticosteroids 
(44.7%), mucolytic (30.2%), non-steroidal anti-in-
flammatory (12.3%) and antitussives (8.3%). 
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Table 6.  Frequency of the inappropriate antibiotic 
treatment.
Clinical items Number %
Tonsillitis 30/92 32.6
AMS 22/56 39.3
AOM 5/12 41.7
Exacerbation od the COPD 23/28 82.1
Pneumonia 8/19 42.1
Table 7.  Duration of the treatment according to the 
clinical diagnosis.
 
Average duration Median
days days
Tonsillitis 6.2 ± 1.7 6
Acute otitis media 8.3 ± 3 8
Acute maxillary sinusitis 7.7 ± 1.4 8
Pneumonia 9.1 ± 2.3 10
Acute bronchitis 7.2 ± 1.7 7
Exacerbations of COPDs 8.4 ± 1.9 8
Table 5.  The antibiotics prescribed during ENT and respiratory infections.
One 
diagnosis
AB Tonsillitis AMS
Exacerbations
of COPDs
Pneumonia AOM Others
More 
than one 
diagnosis
Total 
 n=319 n=113 n=92 n=56 n=28 n=16 n=12 n=2 n=41
n=374
% % % % % % % % %
Penicillin V 0.6 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5
Co-amoxiclav 30.3 33.6 10.1 42.1 39.3 43.8 66.7 50.0 25.0 29.7
Cefuroxime 10.9 6.0 17.2 21.1 0.0 0.0 0.0 0.0 9.1 10.7
Cefpodoxime 5.5 1.7 15.2 1.8 0.0 0.0 0.0 0.0 2.3 5.1
Cefixime 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5
Azithromycin 3.3 1.7 8.1 0.0 0.0 6.3 0.0 0.0 2.3 3.2
Clarithromycin 8.2 12.9 5.1 7.0 0.0 12.5 0.0 50.0 11.4 8.6
Ofloxacin 20.9 29.3 1.0 19.3 60.7 31.3 8.3 0.0 25.0 21.4
Ciprofloxacin 2.1 3.4 1.0 0.0 7.1 0.0 0.0 0.0 2.3 2.1
Levofloxacin 18.2 25.9 0.0 17.5 53.6 31.3 0.0 0.0 20.5 18.4
Gemifloxacin 1.2 1.7 0.0 1.8 3.6 0.0 0.0 0.0 4.5 1.6
Tetracyclines 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5
Combinations 
of 2 or more 
antibiotics
2.4 1.7 1.0 1.8 3.6 12.5 0.0 50.0 6.8 2.9
AB: Acute bronchitis, AOM: Acute otitis media. AMS: Acute maxillary sinusitis. Exacerbations of COPD: Chronic obstructive 
pulmonary disease. Co-amoxiclav: amoxicillin - clavulanic acid.
Among the 374 eligible patients, 363 (97.1%) 
were present at the second visit (V2) after an ave-
rage of 8.1 days (median: 7 days ± 4.6).
The outcome was favorable with improvement 
or recovery in (91.7%). While in 26 cases (7.1%), 
there was either a worsening or lack of improve-
ment. In 15 cases (4%), the outcome could not be 
determined. 
The analysis of outcome based on the location 
of the infection shows clinical success rates ranging 
from 78.9% in case of pneumonia to 90.7% in case 
of acute bronchitis.
The recovery rate tends to be nearly significantly 
higher in patients under 30 years (65.2%) than in 
those aged 60 and more (32 %) (p = 0.05). Fur-
thermore, the proportion of treatment failure tends 
to increase significantly with age, from 4.5% in pa-
tients under 30 years to 12.5% among those 60 
years and older (p = 0.05).
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The total average cost of an infectious episode 
was 79.776 ± 36.988 TND (about 45 ± 20 USD)., 
with a minimum and maximum values respectively 
19.5 and 315.5 TND. 
There are significant variations according to the 
clinical diagnosis. The lowest average cost was ob-
served in tonsillitis, 59.975 TND, while it exceeded 
80 TND in acute otitis media, acute maxillary sinu-
sitis, pneumonia and acute exacerbation of chronic 
obstructive pulmonary disease-COPD. 
Discussion
This study showed that tonsillitis, acute maxillary 
sinusitis and acute bronchitis account for over 90% 
of ENT and respiratory tract infections. Tonsillitis 
and acute maxillary sinusitis are significantly more 
frequent among the young patients, while the fre-
quency of acute bronchitis increases significantly 
with age.
The approach to diagnosis adopted by GPs was 
mainly clinical but additional tests were prescribed 
in 20% of patients. No microbiological tests were 
conducted which did not allow the identification of 
bacteria responsible for infection and its susceptibi-
lity to antibiotics.
This study highlights the frequency of antibiotics 
prescription (96.2%) during supposed viral infec-
tions such as acute bronchitis, tonsillitis or when 
antibiotic prescription has to be debatable such as 
in acute otitis media, sinusitis maxillary or exacer-
bations of COPD. 
An antibiotic treatment was prescribed in 92% of 
cases of tonsillitis while according to epidemiologi-
cal data about 80% are of viral origin. 
The high frequency of antibiotic prescription is 
explained by the practitioner’s concern to prevent 
acute rheumatic fever and the lack of availability 
of rapid diagnostic tests (RDTs) for group A strep-
tococci. 
The cost of RDT would be around 3 TND (1.7 
US$). RDTs use for diagnosis of bacterial tonsillitis 
reduces cost and risk of bacterial resistance based 
on data from a recent study showing that RDT was 
positive only in 33% of cases of tonsillitis [10]. If a 
RTD was conducted in 125 cases of tonsillitis, 74 
antibiotic prescriptions could be avoided leading to 
21% reduction in the cost and preserving the bac-
terial ecology. 
These data should encourage health policy makers 
to recommend this rapid test as a useful tool in the 
diagnosis of streptococcal tonsillitis. This study also 
note the high frequency of macrolides prescription 
for tonsillitis (26.7%) despite the high rate of Strep-
tococcus pyogenes macrolide resistance in Tunisia 
(22.4%) [11].
Although the abstention of antibiotic treatment 
is the rule in acute bronchitis in healthy adult, the 
prescription rate reached 97.1%. The avoidable cost 
of an antibiotic treatment could be 3471.2 TND 
(1930 US$).
Exacerbations of COPD are the most expensive 
respiratory infections in terms of antibiotic treatment, 
additional tests and concomitant treatments are re-
quired. In this study, the antibiotic treatment was 
systematically prescribed during exacerbations of 
the COPD and could have been avoided in 5 cases 
(Grade 0 of COPD) for an avoidable cost of 157.245 
DT (87 USD$).
This study confirms that general practitioners 
tend to prescribe antipyretics (71.4%) and corticos-
teroids (44.7%).
Overall, this study has clarified the prescribing 
patterns of antibiotics in the ENT and respiratory 
tract infections characterized by over-prescribing 
and unnecessary additional costs related to the lack 
of diagnostic tools or excessive fear of complica-
tions. However, it is important to take in account 
some limitations of the study, the results are repre-
sentative for GPs working in the center region of 
Tunisia and who had agreed to participate in this 
study and for the patients within the same region. 
On the other hand, there is a risk of bias due to the 
fact that GPs may change their practice habits du-
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ring the study and adopt a positive attitude to meet 
the recommendations of correct use of antibiotics. 
This study did not have bacteriological data making 
it difficult to distinguish between a viral infection 
and a bacterial infection.
The over-use of antibiotics is also a concern in 
developed countries having guidelines for rational 
use of antibiotics and may lead to emergence of 
bacterial resistance [3, 12, 13].
In case of presumed viral infection, antibiotics are 
useless. A recent study showed that strategies of no 
prescription or delayed antibiotic prescription during 
acute respiratory tract infections are associated with 
less strong beliefs in antibiotics and similar symp-
tomatic outcomes to immediate prescription [14]. 
Patients’ knowledge and expectations may in-
fluence prescription of antibiotics and « patient in-
formation leaflets » could help for awareness and 
to facilitate consultations witch could be useful to 
decrease unnecessary prescribing of antibiotics [15]. 
Conclusion
This study provides real-life data about the clinical 
practices and antibiotic prescriptions for out pa-
tients with ENT and respiratory infections. It shows 
that GPs have been rarely used laboratory tests to 
confirm the diagnosis and widely prescribed anti-
biotics for presumed viral infections. 
This study may serve to set up national guideli-
nes for appropriate antibiotic use in order to reduce 
unnecessary antibiotic prescription and emerging of 
bacterial resistance. 
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